sar425899 sanofi dual glp-1 glucagon agonist How glucagon-like peptide 1 receptor agonists work Glucagon-like peptide 1 (GLP-1) -

PMID: 23736544

How can a holistic approach, including breathwork and group support, enhance weight management and behavioral change

Alternative weight loss interventions include phentermine/topiramate, naltrexone/bupropion, orlistat, bariatric surgery, or intensive lifestyle modification programs

Muscle loss during GLP-1 weight loss is typically linked to: Low protein intake Large calorie deficits Reduced resistance training Rapid or unstructured weight loss Weight loss always includes a mix of fat and lean mass loss, but research on GLP-1 medications suggests that while fat loss is predominant, some lean mass loss can occur depending on dietary intake and physical activity levels